Open access
76
Views
54
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study
Ronald Dahl1 Department of Dermatology, Allergy Centre, Odense University Hospital, Odense, DenmarkCorrespondence[email protected]
, Dalal Jadayel2 Novartis Horsham Research Centre, Horsham, UK
, Vijay KT Alagappan3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Hungta Chen3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
& Donald Banerji3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 501-508
|
Published online: 17 Oct 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.